MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.78MP/E –Yield –
MariMed operating margin
Operating margin is operating income as a percentage of revenue.
MariMed's operating margin for the twelve months ending Jun 30, 2026 was -1.5%. For fiscal 2025 it was -1.8%, against 1.7% the year before. The highest annual figure on record is 28.6% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.8% | −3.4 |
| FY2024 | Dec 31, 2024 | 1.7% | −8.0 |
| FY2023 | Dec 31, 2023 | 9.7% | −5.5 |
| FY2022 | Dec 31, 2022 | 15.2% | −6.9 |
| FY2021 | Dec 31, 2021 | 22.1% | −6.4 |
| FY2020 | Dec 31, 2020 | 28.6% | +119.6 |
| FY2019 | Dec 31, 2019 | -91.1% | −45.9 |
| FY2018 | Dec 31, 2018 | -45.2% | −47.3 |
| FY2017 | Dec 31, 2017 | 2.1% | −19.6 |
| FY2016 | Dec 31, 2016 | 21.8% | +154.9 |
| FY2015 | Dec 31, 2015 | -133.1% | +791.7 |
| FY2014 | Dec 31, 2014 | -924.8% | +60816.9 |
| FY2013 | Dec 31, 2013 | -61741.7% | +36957.3 |
| FY2012 | Dec 31, 2012 | -98699.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.0% | −1.6 |
| Q1 FY2026 | Mar 31, 2026 | 0.3% | +2.7 |
| Q4 FY2025 | Dec 31, 2025 | -10.9% | −7.1 |
| Q3 FY2025 | Sep 30, 2025 | 3.9% | +0.6 |
| Q2 FY2025 | Jun 30, 2025 | 2.6% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | -2.4% | −7.7 |
| Q4 FY2024 | Dec 31, 2024 | -3.8% | −10.0 |
| Q3 FY2024 | Sep 30, 2024 | 3.3% | −5.2 |
| Q2 FY2024 | Jun 30, 2024 | 2.4% | −7.3 |
| Q1 FY2024 | Mar 31, 2024 | 5.3% | −9.6 |
| Q4 FY2023 | Dec 31, 2023 | 6.2% | −2.4 |
| Q3 FY2023 | Sep 30, 2023 | 8.5% | −8.4 |
| Q2 FY2023 | Jun 30, 2023 | 9.7% | −3.9 |
| Q1 FY2023 | Mar 31, 2023 | 14.9% | −7.6 |
| Q4 FY2022 | Dec 31, 2022 | 8.6% | +4.7 |
| Q3 FY2022 | Sep 30, 2022 | 16.9% | −11.6 |
| Q2 FY2022 | Jun 30, 2022 | 13.6% | −25.9 |
| Q1 FY2022 | Mar 31, 2022 | 22.5% | −2.7 |
| Q4 FY2021 | Dec 31, 2021 | 3.9% | −18.0 |
| Q1 FY2021 | Mar 31, 2021 | 28.6% | +15.1 |
| Q4 FY2020 | Dec 31, 2020 | 39.5% | +957.0 |
| Q3 FY2020 | Sep 30, 2020 | 25.2% | +16.6 |
| Q2 FY2020 | Jun 30, 2020 | 21.8% | +1.0 |
| Q1 FY2020 | Mar 31, 2020 | 13.5% | +19.8 |
| Q4 FY2019 | Dec 31, 2019 | -917.5% | −773.9 |
| Q3 FY2019 | Sep 30, 2019 | 8.7% | +24.9 |
| Q2 FY2019 | Jun 30, 2019 | 20.8% | +5.8 |
| Q1 FY2019 | Mar 31, 2019 | -6.3% | +9.1 |
| Q4 FY2018 | Dec 31, 2018 | -143.6% | −81.0 |
| Q3 FY2018 | Sep 30, 2018 | -16.2% | −32.9 |
| Q2 FY2018 | Jun 30, 2018 | 15.0% | −22.1 |
| Q1 FY2018 | Mar 31, 2018 | -15.4% | −35.3 |
| Q4 FY2017 | Dec 31, 2017 | -62.6% | −105.3 |
| Q3 FY2017 | Sep 30, 2017 | 16.7% | +10.4 |
| Q2 FY2017 | Jun 30, 2017 | 37.1% | +21.9 |
| Q1 FY2017 | Mar 31, 2017 | 19.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 42.7% | – |
| Q3 FY2016 | Sep 30, 2016 | 6.3% | – |
| Q2 FY2016 | Jun 30, 2016 | 15.2% | – |
See a number that looks wrong?